Compare Quest Diagnostics Inc (DGX) vs Ecopetrol SA (EC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Ecopetrol SA — how do they compare? Quest Diagnostics Inc trades at $229.97 (market cap $25.48B), while Ecopetrol SA trades at $16.91 (market cap $33.11B). The key difference: Ecopetrol SA is the larger of the two by market cap, and Ecopetrol SA pays the higher dividend (3.83%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Ecopetrol SA for 84 Days on average.
| DGX | EC | |
|---|---|---|
Market Cap | $25.48B | $33.11B |
Volume | 941,866 | 993,598 |
Sector | Health | Energy |
52-Week High | $247.45 | $18.26 |
52-Week Low | $173.49 | $8.61 |
Typical Hold Time | 56 Days | 84 Days |
Enterprise Value | $31.23B | $61.36B |
Dividend Yield | 1.49% | 3.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.
The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.
Ecopetrol (EC) trades at $17.07, up 2.65% on the day, but faces a bearish technical signal with recent earnings misses. Revenue declined to $119.69T in 2025, with net income margin at 8.76%, though profitability metrics like ROE (17.67%) remain solid. The company is undergoing senior management changes amid government-led board restructuring, creating uncertainty.
The outlook is mixed: low valuations (P/E 7.97, EV/EBITDA 4) suggest potential upside, but declining revenue, earnings volatility, and political interference pose significant risks. Analyst consensus is cautious with a $16.85 price target below current levels, indicating limited near-term catalysts for substantial growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →
